20509 results for «»

Filter By

20509 results

Risto Jussila

Finland

Tomi Kaukonen

Hämeenlinna, Finland

Martin Kirk Christensen

Denmark

Olli-Pekka Piira

Oulu, Finland

Christian Templin

Zurich, Switzerland

The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support

10 Feb 2020

The use of MCS has been increasing over the last 10 years. This study mainly aims at defining the indications for Impella use in the U.S as well as comparing the outcomes, costs, and length of stay in the pre-Impella versus Impella era.

Manal Alasnag

Reviewer

Manal Alasnag
Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
The evolving landscape of Impella use in the United States among patients undergoing PCI with MCS

Treatment of aortic stenosis in patients with longer life expectancy: case-based heart team discussion

26 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session with a case-based heart team discussion to learn more about the treatment of aortic stenosis in patients with longer life expectancy: discover what the 2021 guidelines say about patient selection, what should be considered for patients with longer life expectancy, and how to optimise procedural outcome.

Treatment of aortic stenosis in patients with longer life expectancy: case-based heart team discussion

Case-based challenging edge-to-edge mitral repair

26 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on mitral valve repair to learn how to successfully perform this procedure, especially in patients with challenging anatomies, and how to face any possible complications.

Case-based challenging edge-to-edge mitral repair

Case-based challenging TAVI

26 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session with challenging TAVI cases to learn more about indication and choice of treatment for patients with aortic stenosis, and discover some interesting tips and tricks to face tough situations. 

Case-based challenging TAVI

Tailoring mitral repair and optimising clinical outcomes using MitraClip G4

27 Sep 2021 – From PCR Tokyo Valves 2021

Using the one-year results of the EXPAND study and the 30-day results of the EXPAND G4 study, this session highlights the value of the latest generation of MitraClip technologies, providing an overview of the strengths of the MitraClip G4 and its practical use on 2 case...

Tailoring mitral repair

Why durability matters: lifetime management considerations for supra-annular TAVR

26 Sep 2021 – From PCR Tokyo Valves 2021

In this session, the speakers address the problem of the evolution of clinical data for TAVI from extreme to low risk based on a number of studies on the subject, such as CoreValve Pivotal Study, Partner Study, SURTAVI Study, or Evolut Low-Risk Study, and then focus...

Why durability matters: lifetime management considerations for supra-annular TAVR

Mechanical thrombectomy with retrievable stents and aspiration catheters for acute ischaemic stroke: a meta-analysis of randomised controlled trials

29 Sep 2021

The current meta-analysis highlights that mechanical thrombectomy with retrievable stents or aspiration catheters reduced disability and all-cause mortality at 90 days in acute anterior circulation ischaemic stroke.

Reviewer

Ali Nazmi Calik

Reviewer

Levent Pay
Mechanical thrombectomy with retrievable stents and aspiration catheters for acute ischaemic stroke: a meta-analysis of randomised controlled trials

Placebo-controlled efficacy of percutaneous coronary intervention for focal and diffuse patterns of stable coronary artery disease

29 Oct 2021

According to the updated international revascularization guidelines, fractional flow reserve (FFR) and instantaneous wave-free period ratio (iFR) are proposed to dichotomize decision-making for ischemia detection in guiding percutaneous coronary intervention (PCI) of intermediate coronary stenosis.

M. Pighi

Reviewer

Michele Pighi
Simone Fezzi

Reviewer

Simone Fezzi
Placebo-controlled efficacy of percutaneous coronary intervention for focal and diffuse patterns of stable coronary artery disease

Levent Pay

Istanbul, Türkiye

Matteo Ziacchi

Matteo Ziacchi

Percutaneous myocardial revascularization in late-presenting patients with STEMI

30 Sep 2021

Through this registry-based analysis, the authors sought to assess short and long-term outcomes of revascularisation in a latecomer STEMI population presenting between 12 to 48 hours of symptom onset.

Reviewer

Aaysha Cader
Saidur Rahman Khan

Reviewer

Saidur Rahman Khan
Percutaneous myocardial revascularization in late-presenting patients with STEMI

Treating complex coronary lesions: right case right time Prevail™ DCB

01 Oct 2021 – From AICT-AsiaPCR 2021

Thanks to this session, find out more about indications for drug-coated balloons, or, on the contrary, learn when not to use it. And through the analysis of two concrete cases, see how DCB can be an important tool to tackle increasingly complex patients and anatomies, especially...

Treating complex coronary lesions: right case right time Prevail™ DCB

Telescope guide extension catheter in complex coronary interventions

01 Oct 2021 – From AICT-AsiaPCR 2021

View the complex case of this 70-year-old male patient with hypertension and diabetes who presented with chest pain and NSTEMI, which shows that, when dealing with challenging calcific disease, guide catheter extensions help improve device delivery.

Telescope guide extension

MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

01 Oct 2021 – From AICT-AsiaPCR 2021

In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.

MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

Renal denervation in the real-world: performance in high risk subgroups

05 Oct 2021 – From AICT-AsiaPCR 2021

After having evoked in particular the SPRAL HTN Global Clinical Program, the RDN consensus statements, the EHS position paper 2021, the ARDeC, and the STEP Trial, Tzung-Dau Wang shares his experience in using renal denervation to manage uncontrolled hypertension by illustrating his words with the case...

Renal denervation in
Didn’t find what you were looking for?